Enjaymo to decrease the need for transfusion due to cold agglutinin disease
Drug Name: Enjaymo Indications: To decrease the need for red blood cell transfusion due to hemolysis in cold agglutinin disease. Active Ingredient: Sutimlimab-jome Company: Bioverativ USA Inc (a Sanofi company)…